Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case reportXiaoyuan He, Mingfeng Zhao, Yanyu Jiang et al.|Blood Advances|2024Cited by 5
The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022Zhengyu Yu, Ting Niu, Li Xie et al.|Frontiers in Oncology|2023Cited by 3